MGC Pharmaceuticals Limited (MXC) RNS Announcements

Showing 51–100 of 209 announcements

MGC Pharmaceuticals Limited RNS

MGC Pharmaceuticals Limited RNS

Date	Time	Date	TitleTitle (filtered)
30/06/23	09:31:08	30 Jun 2023	Details of Company Address	Details of Company Address
30/06/23	09:30:18	30 Jun 2023	Company Update	Company Update
29/06/23	10:22:14	29 Jun 2023	Results of Shareholder’s General Meeting	Results of Shareholder’s General Meeting
01/06/23	07:30:01	1 Jun 2023	Appointment of Non-Executive Director	Appointment of Non-Executive Director
31/05/23	07:00:07	31 May 2023	First CannEpil® delivered to UK patients	First CannEpil® delivered to UK patients
30/05/23	07:01:02	30 May 2023	Corporate Update - Board and UK Adviser Changes	Corporate Update - Board and UK Adviser Changes
30/05/23	07:00:09	30 May 2023	Dispatch of General Meeting Documents	Dispatch of General Meeting Documents
18/05/23	12:00:02	18 May 2023	Director/PDMR Shareholding	Director/PDMR Shareholding
10/05/23	17:05:40	10 May 2023	Director/PDMR Shareholding	Director/PDMR Shareholding
02/05/23	07:00:13	2 May 2023	Malta Production Facility Receives EU-GMP Approval	Malta Production Facility Receives EU-GMP Approval
28/04/23	07:13:51	28 Apr 2023	March 2023 Quarterly Activities and Cash Flow	March 2023 Quarterly Activities and Cash Flow
13/04/23	07:00:05	13 Apr 2023	Fundraise closed raising a total of £2,090,890	Fundraise closed raising a total of £2,090,890
11/04/23	07:01:02	11 Apr 2023	£1.2 million raised in a conditional Placing	£1.2 million raised in a conditional Placing
11/04/23	07:00:08	11 Apr 2023	CannEpil® available by Named Patient Request in UK	CannEpil® available by Named Patient Request in UK
03/04/23	07:00:16	3 Apr 2023	Approval to Develop and Research with Psilocybin	Approval to Develop and Research with Psilocybin
21/03/23	09:05:56	21 Mar 2023	Second Price Monitoring Extn	Second Price Monitoring Extn
21/03/23	09:00:31	21 Mar 2023	Price Monitoring Extension	Price Monitoring Extension
21/03/23	07:00:00	21 Mar 2023	ArtemiC Listed as OTC Drug; AMC Places US$2m order	ArtemiC Listed as OTC Drug; AMC Places US$2m order
15/03/23	16:35:34	15 Mar 2023	Price Monitoring Extension	Price Monitoring Extension
15/03/23	07:00:09	15 Mar 2023	First patient enrolled in MGC ZAM App	First patient enrolled in MGC ZAM App
08/03/23	09:00:01	8 Mar 2023	US$500,000 funding received under Mercer Facility	US$500,000 funding received under Mercer Facility
07/03/23	07:00:06	7 Mar 2023	Completion of CimetrA™ Mechanism of Action study	Completion of CimetrA™ Mechanism of Action study
01/03/23	07:02:33	1 Mar 2023	Appointment of UK Lead Broker and Change of Co Sec	Appointment of UK Lead Broker and Change of Co Sec
28/02/23	09:08:26	28 Feb 2023	Half-year Report	Half-year Report
10/02/23	08:45:50	10 Feb 2023	Updated Investor Presentation	Updated Investor Presentation
03/02/23	07:00:04	3 Feb 2023	Provision of US$600,000 funding and change of CFO	Provision of US$600,000 funding and change of CFO
02/02/23	07:00:05	2 Feb 2023	Extension of Convertible Securities Agreements	Extension of Convertible Securities Agreements
30/01/23	07:00:04	30 Jan 2023	December 2022 Quarterly Activities and Cash Flow	December 2022 Quarterly Activities and Cash Flow
23/01/23	16:40:47	23 Jan 2023	Second Price Monitoring Extn	Second Price Monitoring Extn
23/01/23	16:35:21	23 Jan 2023	Price Monitoring Extension	Price Monitoring Extension
16/01/23	07:00:06	16 Jan 2023	Change of Adviser – SW4 Partners	Change of Adviser – SW4 Partners
11/01/23	09:01:28	11 Jan 2023	Change in External Financial Auditor	Change in External Financial Auditor
10/01/23	07:00:04	10 Jan 2023	Completion of CimetrA™ Pre-clinical Trial	Completion of CimetrA™ Pre-clinical Trial
03/01/23	07:00:09	3 Jan 2023	Internal Costs Review Completed and Board Change	Internal Costs Review Completed and Board Change
28/12/22	09:10:54	28 Dec 2022	A$800,000 funding received under Mercer Facility	A$800,000 funding received under Mercer Facility
07/12/22	07:00:07	7 Dec 2022	Completion of CimetrA Efficacy Pre-clinical Trial	Completion of CimetrA Efficacy Pre-clinical Trial
05/12/22	07:00:04	5 Dec 2022	Delivery of US$1m order of ArtemiC to AMC Holdings	Delivery of US$1m order of ArtemiC to AMC Holdings
02/12/22	07:00:11	2 Dec 2022	Publication of MGC Pharma Glioblastoma research	Publication of MGC Pharma Glioblastoma research
28/11/22	07:00:09	28 Nov 2022	Result of AGM and Investor Presentation	Result of AGM and Investor Presentation
22/11/22	07:00:10	22 Nov 2022	Website Update	Website Update
16/11/22	09:00:01	16 Nov 2022	Notice of AGM	Notice of AGM
09/11/22	10:20:01	9 Nov 2022	Application for Admission to Trading	Application for Admission to Trading
31/10/22	07:00:08	31 Oct 2022	September Quarterly Activities and Cash Flow	September Quarterly Activities and Cash Flow
25/10/22	07:00:06	25 Oct 2022	ArtemiC Support - Long COVID Clinical Study Resuls	ArtemiC Support - Long COVID Clinical Study Resuls
20/10/22	07:00:05	20 Oct 2022	Operations Update – Major Milestones Achieved	Operations Update – Major Milestones Achieved
18/10/22	09:00:04	18 Oct 2022	2022 AGM Notice of Meeting and Annual Report	2022 AGM Notice of Meeting and Annual Report
05/10/22	13:03:25	5 Oct 2022	Results of Shareholder’s General Meeting	Results of Shareholder’s General Meeting
04/10/22	07:00:06	4 Oct 2022	Appointment of UK Advisor and Company Update	Appointment of UK Advisor and Company Update
03/10/22	07:00:13	3 Oct 2022	Annual Financial Report	Annual Financial Report
28/09/22	16:41:17	28 Sept 2022	Second Price Monitoring Extn	Second Price Monitoring Extn